These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23754771)

  • 61. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.
    Greil W; Zhang X; Stassen H; Grohmann R; Bridler R; Hasler G; Toto S; Bleich S; Kasper S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The development and piloting of "ATTEND DR," a clinical teaching tool to identify and prioritize potential causes of adverse drug reactions.
    King M; Khan S
    Curr Pharm Teach Learn; 2017; 9(1):66-71. PubMed ID: 29180157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.
    Logan BK; Mohr ALA; Friscia M; Krotulski AJ; Papsun DM; Kacinko SL; Ropero-Miller JD; Huestis MA
    J Anal Toxicol; 2017 Sep; 41(7):573-610. PubMed ID: 28459969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Consumption of antihistamines in Serbia in the period 2011-2015 and the correlation with adverse drug reaction reports.
    Radonjić V; Jović I; Kalaba M; Godman B; Košutić J
    Vojnosanit Pregl; 2016 Nov; 73(11):1076-7. PubMed ID: 29341563
    [No Abstract]   [Full Text] [Related]  

  • 65. The incidence and reporting of adverse drug reactions in the Division of Psychiatry.
    Brown P; Faloon L
    Pharm World Sci; 2001 Oct; 23(5):181-2. PubMed ID: 11721674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A supervised adverse drug reaction signalling framework imitating Bradford Hill's causality considerations.
    Reps JM; Garibaldi JM; Aickelin U; Gibson JE; Hubbard RB
    J Biomed Inform; 2015 Aug; 56():356-68. PubMed ID: 26116429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Gershman MD; Staples JE; Bentsi-Enchill AD; Breugelmans JG; Brito GS; Camacho LA; Cottin P; Domingo C; Durbin A; Gascon J; Guenaneche F; Hayes EB; Jelenik Z; Khromava A; Martins Rde M; Wilson MM; Massy N; Nasidi A; Niedrig M; Sherwat A; Tsai T; Vilella A; Wilson ME; Kohl KS;
    Vaccine; 2012 Jul; 30(33):5038-58. PubMed ID: 22561144
    [No Abstract]   [Full Text] [Related]  

  • 68. Statistical methods for the analysis of adverse event data.
    Kieser M
    Pharm Stat; 2016 Jul; 15(4):290-1. PubMed ID: 27324410
    [No Abstract]   [Full Text] [Related]  

  • 69. Effective assessment of psychotropic medication side effects using PsyLOG mobile application.
    Rojnic Kuzman M; Andlauer O; Burmeister K; Dvoracek B; Lencer R; Koelkebeck K; Maric NP; Nawka A; Pantovic-Stefanovic M; Riese F; Aukst Margetic B; Bosnjak D; Ruzic MC; Curkovic M; Grubsin J; Madzarac Z; Makaric P; Petric D; Radic K; Savic A
    Schizophr Res; 2018 Feb; 192():211-212. PubMed ID: 28457773
    [No Abstract]   [Full Text] [Related]  

  • 70. Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.
    Pirmohamed M
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):62-4. PubMed ID: 20213370
    [No Abstract]   [Full Text] [Related]  

  • 71. Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data.
    Allen EN; Chandler CI; Mandimika N; Pace C; Mehta U; Barnes KI
    Malar J; 2013 Sep; 12():325. PubMed ID: 24041367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Edema related to treatment with psychotropic drugs.
    Engel J; Haack B; Zolk O; Greiner T; Heinze M; Toto S; Seifert J; Bleich S; Glocker C; Grohmann R; Schneider M; Stübner S
    J Neural Transm (Vienna); 2024 Mar; 131(3):253-266. PubMed ID: 38353811
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Re: adverse drug reactions in older patients during hospitalisation: are they predictable?
    Griebling T
    J Urol; 2013 Aug; 190(2):623. PubMed ID: 23845357
    [No Abstract]   [Full Text] [Related]  

  • 74. Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms.
    Venning GR
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):249-52. PubMed ID: 6799125
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recognition and assessment of adverse drug reactions in children.
    Venulet J
    Bratisl Lek Listy; 1991 Nov; 92(11):540-3. PubMed ID: 1806164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Should patients be informed about the side effects of psychotropic drugs? According to us: Yes.
    Atmaca M; Korucu T; Cekic S; Kazgan A; Keles DD; Tabara MF; Baykara S; Korkmaz S
    Psychiatry Res; 2018 Dec; 270():176-179. PubMed ID: 30261406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Understanding the assessment of psychotropic drug harms in clinical trials to improve social workers' role in medication monitoring.
    Hughes S; Cohen D
    Soc Work; 2010 Apr; 55(2):105-15. PubMed ID: 20408352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessing drug causality: It is time to become European!
    Bégaud B
    Pharmacol Res; 2017 Sep; 123():158. PubMed ID: 28694143
    [No Abstract]   [Full Text] [Related]  

  • 79. Adverse drug reactions: definitions, diagnosis, and management.
    Edwards IR; Aronson JK
    Lancet; 2000 Oct; 356(9237):1255-9. PubMed ID: 11072960
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis.
    Onakpoya IJ; Heneghan CJ; Aronson JK
    Crit Rev Toxicol; 2016 Jul; 46(6):477-89. PubMed ID: 26941185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.